With nearly all its employees working remotely since April 2020, Tata Consultancy Services (TCS) has reduced its absolute carbon footprint by 49% over the last year.
After conquering telecom connectivity within India, the country's richest man, Mukesh Ambani, is now all set to place the country at the centre of an international submarine cable network.
Indian students who are set to attend foreign universities this year are struggling to get vaccinated, which is one of the pre-requisite for entering several countries and attending classes on many campuses.
June 1, 2021
One man in India is worried that his Covid-19 vaccine shot may not be working.
Pratap Chandra, a resident of Lucknow in Uttar Pradesh, got himself tested for antibodies against Covid, 28 days after receiving the Covishield jab. After the test concluded that he had no antibodies against the viral infection, he concluded that the vaccine maker and India’s health ministry were to blame.
Covishield, the AstraZeneca vaccine manufactured by the Serum Institute of India, is the dominant vaccine in the country’s ongoing immunisation programme. So far, a majority of the 216 million doses administered in India have been of Covishield.